Sirio Pharma, the global nutraceutical contract development and manufacturing organization (CDMO) headquartered in Europe, will launch a women’s health platform that includes hormone health, women’s wellness
Endo family of businesses (Par Pharmaceutical, Inc. in particular) have announced a generic launch of Duexis tablets 800 mg/26.6 mg, the version in which the active pharmaceutical ingredient of Duexis is famotidine.
affordable and timely diagnosis of lifestyle-related diseases has become a growing issue in the present world, where life habit changes occur and cause complexity.
The leading global pharmaceutical company Lupin Limited (Lupin) revealed that it had been authorized by the United States Food and Drug Administration (FDA) to provide an abbreviated new drug application
In connection with the International Institute of Health Management with Research International Delhi and the Indian Institute of Technology (IIT) Bombay, UNICEF has developed a digital course that healthcare professionals
Biocon received approval for its complex drug-device combination Liraglutide (6mg/ml solution for injection in a pre-filled pen) from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).
The prioritization of medicines (PRIME) status has been granted to pegozafermin, a drug developed by 89bio for the non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH)
Healis Therapeutics, a company focused on neurotherapeutics, has recently announced its clinical collaboration with General Hospital (MGH) and Harvard Medical School (HMS) affiliates.
According to recent reports from Russian media, India emerged as the largest pharmaceutical supplier to Russia in 2023, replacing the previously dominant Western companies.
Indian pharmaceutical companies are currently focused on developing flagship products or mother brands. These are designed to incorporate various new combinations and ensure robust revenue growth and therapy leadership.
, CDSCO.jpg)
.jpg)